Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2026 Earnings Call Transcript February 12, 2026 Aethlon Medical, Inc. misses on earnings expectations. Reported EPS is $-2.45 EPS, expectations were $-2.01.

Tasso and InnoVero developed a less-invasive anti-doping blood test being used broadly at the Olympics for the first time.

Negotiations to avert a partial government shutdown are being complicated by Democratic demands that any changes to Immigration and Customs Enforcement policy be written into law by Congress. Senate ...

King's College London researchers have created a unique collection of human stem cell models that could help to uncover why ...

Macy is a writer on the AI Team. She covers how AI is changing daily life and how to make the most of it. This includes writing about consumer AI products and their real-world impact, from ...

Months ago, District Attorney Brooke Jenkins warned she would consider prosecuting Trump's immigration agents if they broke the law. Now, she sees the fatal shootings in Minneapolis as a call to ...

Seventy-five percent of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) who were treated with the antibody ...

Myelodysplastic syndromes (MDS) can damage bone marrow, lowering red blood cells and platelets. Transfusions replace missing cells to manage anemia or thrombocytopenia. Up to 9 in 10 people with MDS ...

Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. A liver function test checks how ...

If I were to flip you the bird left-handed, which I sometimes do to mix things up, you’d notice that my middle finger is crooked, with a bulged knuckle. Why does it look like that? Catfish noodling.